Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Annexin 1 protein (ANXA1) expression was evaluated in tumor and mast cells in human larynx cancer and control epithelium. The effect of the exogenous ANXA1 (peptide Ac 2-26) was also examined during the cellular growth of the Hep-2 human larynx epidermoid carcinoma cell line. This peptide inhibited the proliferation of the Hep-2 cells within 144 hr. In surgical tissue specimens from 20 patients with larynx cancer, ultrastructural immunocytochemistry analysis showed in vivo down-regulation of ANXA1 expression in the tumor and increased in mast cells and Hep-2 cells treated with peptide Ac2-26. Combined in vivo and in vitro analysis demonstrated that ANXA1 plays a regulatory role in laryngeal cancer cell growth. We believe that a better understanding of the regulatory mechanisms of ANXA1 in tumor and mast cells may lead to future biological targets for the therapeutic intervention of human larynx cancer.

Original publication




Journal article


Int J Cancer

Publication Date





2582 - 2589


Aged, Aged, 80 and over, Annexin A1, Cell Line, Tumor, Epithelial Cells, Gene Expression, Gene Expression Profiling, Humans, Immunohistochemistry, Laryngeal Neoplasms, Larynx, Male, Mast Cells, Microscopy, Immunoelectron, Middle Aged, Peptides, RNA, Messenger, Reverse Transcriptase Polymerase Chain Reaction, Time Factors, Tryptases